News Conference News ESC 2020 New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials Caitlin E. Cox September 03, 2020
News Daily News COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill Michael O'Riordan May 19, 2020
News Daily News COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say Yael L. Maxwell April 20, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Features Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019 L.A. McKeown December 12, 2019
News Conference News ACC 2019 Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being Yael L. Maxwell March 28, 2019
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Conference News EuroPCR 2018 Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care Michael O'Riordan May 21, 2018
News Conference News ACC 2018 My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up Shelley Wood March 27, 2018
News Daily News Medtronic’s Riptide System Cleared for Thrombus Aspiration in Acute Stroke Todd Neale January 16, 2018
News Daily News Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early Todd Neale October 09, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Opinion Editor's Corner ESC 2017 My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back Shelley Wood September 08, 2017